Abstract
The objective of this study is to evaluate the predictive values of baseline thyroid-stimulating hormone and the rate of thyroid-stimulating hormone change within the euthyroid state on the development of chronic kidney disease. We conducted a longitudinal study in 17,067 Korean adults with normal thyroid function and no history of thyroid disease. Incident chronic kidney disease was defined as an estimated glomerular filtration rate <60 ml/min/1.73 m2. The rate of thyroid-stimulating hormone change was determined by subtracting the baseline thyroid-stimulating hormone level from the thyroid-stimulating hormone level measured at the last visit prior to the diagnosis of chronic kidney disease or at the final visit in subjects without chronic kidney disease, divided by the observation period (years). Subjects were stratified into quintiles according to rates of thyroid-stimulating hormone change. During 86,583 person-years of follow-up (median follow-up 5.2 years), there were 561 incident cases of chronic kidney disease. The risk of incident chronic kidney disease was significantly higher in subjects with rapid increases (quintile 5) or decreases (quintile 1) in thyroid-stimulating hormone levels compared to the reference group (quintile 3). In fully adjusted models, the hazard ratios of quintiles 1 and 5 were 3.15 (95 % confidence interval 2.34 to 4.24; p < 0.001) and 3.37 (95 % confidence interval 2.52 to 4.51; p < 0.001), respectively. However, there was no significant association between baseline thyroid-stimulating hormone and risk of incident chronic kidney disease. The development of chronic kidney disease is associated with the rate of changes in thyroid-stimulating hormone level rather than with baseline thyroid-stimulating hormone levels.
Similar content being viewed by others
References
M.S. Parmar, Chronic renal disease. BMJ. 325(7355), 85–90 (2002)
G. Eknoyan, N. Lameire, K. Eckardt, B. Kasiske, D. Wheeler, A. Levin, P. Stevens, R. Bilous, E. Lamb, J. Coresh, KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney. Int. 3, 5–14 (2013)
C.S. Fox, M.G. Larson, E.P. Leip, B. Culleton, P.W. Wilson, D. Levy, Predictors of new-onset kidney disease in a community-based population. JAMA. 291(7), 844–850 (2004). doi:10.1001/jama.291.7.844
M.K. Haroun, B.G. Jaar, S.C. Hoffman, G.W. Comstock, M.J. Klag, J. Coresh, Risk factors for chronic kidney disease: A prospective study of 23,534 men and women in Washington County, Maryland. J. Am. Soc. Nephrol. 14(11), 2934–2941 (2003)
F. Celsing, E. Blomstrand, J. Melichna, N. Terrados, N. Clausen, P.E. Lins, E. Jansson, Effect of hyperthyroidism on fibre-type composition, fibre area, glycogen content and enzyme activity in human skeletal muscle. Clin. Physiol. 6(2), 171–181 (1986)
G. Basu, A. Mohapatra, Interactions between thyroid disorders and kidney disease. Indian J. Endocrinol. Metab. 16(2), 204–213 (2012). doi:10.4103/2230-8210.93737
A. Woodward, S. McCann, M. Al-Jubouri, The relationship between estimated glomerular filtration rate and thyroid function: An observational study. Ann. Clin. Biochem. 45(Pt 5), 515–517 (2008). doi:10.1258/acb.2008.007248
G. Lippi, M. Montagnana, G. Targher, G.L. Salvagno, G.C. Guidi, Relationship between thyroid status and renal function in a general population of unselected outpatients. Clin. Biochem. 41(7-8), 625–627 (2008). doi:10.1016/j.clinbiochem.2008.01.014
J.C. Lo, G.M. Chertow, A.S. Go, C.Y. Hsu, Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney. Int. 67(3), 1047–1052 (2005). doi:10.1111/j.1523-1755.2005.00169.x
L.H. Mariani, J.S. Berns, The renal manifestations of thyroid disease. J. Am. Soc. Nephrol. 23(1), 22–26 (2012). doi:10.1681/ASN.2010070766
M.J. Diekman, M.P. Harms, E. Endert, W. Wieling, W.M. Wiersinga, Endocrine factors related to changes in total peripheral vascular resistance after treatment of thyrotoxic and hypothyroid patients. Eur. J. Endocrinol. 144(4), 339–346 (2001)
A.D. Toft, N.A. Boon, Thyroid disease and the heart. Heart. 84(4), 455–460 (2000)
Y. Zhang, Y. Chang, S. Ryu, J. Cho, W.Y. Lee, E.J. Rhee, M.J. Kwon, R. Pastor-Barriuso, S. Rampal, W.K. Han, H. Shin, E. Guallar, Thyroid hormone levels and incident chronic kidney disease in euthyroid individuals: The Kangbuk samsung health study. Int. J. Epidemiol. 43(5), 1624–1632 (2014). doi:10.1093/ije/dyu126
B.O. Asvold, T. Bjoro, L.J. Vatten, Association of thyroid function with estimated glomerular filtration rate in a population-based study: The HUNT study. Eur. J. Endocrinol. 164(1), 101–105 (2011). doi:10.1530/EJE-10-0705
M.T. Sun, F.C. Hsiao, S.C. Su, D. Pei, Y.J. Hung, Thyrotropin as an independent factor of renal function and chronic kidney disease in normoglycemic euthyroid adults. Endocr. Res. 37(3), 110–116 (2012). doi:10.3109/07435800.2011.640374
S.H. Song, I.S. Kwak, D.W. Lee, Y.H. Kang, E.Y. Seong, J.S. Park, The prevalence of low triiodothyronine according to the stage of chronic kidney disease in subjects with a normal thyroid-stimulating hormone. Nephrol. Dial. Transplant. 24(5), 1534–1538 (2009). doi:10.1093/ndt/gfn682
American Diabetes, A., Standards of medical care in diabetes--2014. Diabetes. Care. 37(Suppl 1), S14–S80 (2014). doi:10.2337/dc14-S014
S.Y. Sohn, H.J. Kim, H.W. Jang, S.W. Kim, J.H. Chung, Lack of association between high serum thyroid-stimulating hormone level and risk of papillary thyroid microcarcinomas. Head Neck 36(1), 43–46 (2014). doi:10.1002/hed.23252
A.S. Levey, L.A. Stevens, C.H. Schmid, Y.L. Zhang, A.F. Castro 3rd, H.I. Feldman, J.W. Kusek, P. Eggers, F. Van Lente, T. Greene, J. Coresh, A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150(9), 604–612 (2009)
S. Naf, X. Escote, M. Ballesteros, R.E. Yanez, I. Simon-Muela, P. Gil, G. Albaiges, J. Vendrell, A. Megia, Serum activin A and follistatin levels in gestational diabetes and the association of the activin a-follistatin system with anthropometric parameters in offspring. PLoS. One. 9(4), e92175 (2014). doi:10.1371/journal.pone.0092175
G. Karanikas, M. Schutz, M. Szabo, A. Becherer, K. Wiesner, R. Dudczak, K. Kletter, Isotopic renal function studies in severe hypothyroidism and after thyroid hormone replacement therapy. Am. J. Nephrol. 24(1), 41–45 (2004). doi:10.1159/000075628
C. Villabona, M. Sahun, M. Roca, J. Mora, N. Gomez, J.M. Gomez, R. Puchal, J. Soler, Blood volumes and renal function in overt and subclinical primary hypothyroidism. Am. J. Med. Sci. 318(4), 277–280 (1999)
Thyroid Function Testing. Thyroid hormone metabolism. Springer, New York, (2010)
R. Hoermann, J.E. Midgley, R. Larisch, J.W. Dietrich, Integration of peripheral and glandular regulation of triiodothyronine production by thyrotropin in untreated and thyroxine-treated subjects. Horm. Metab. Res. 47(9), 674–680 (2015). doi:10.1055/s-0034-1398616
B.O. Asvold, L.J. Vatten, K. Midthjell, T. Bjoro, Serum TSH within the reference range as a predictor of future hypothyroidism and hyperthyroidism: 11-year follow-up of the HUNT study in Norway. J. Clin. Endocrinol. Metab. 97(1), 93–99 (2012). doi:10.1210/jc.2011-1724
R. Hoermann, J.E. Midgley, R. Larisch, J.W. Dietrich, Homeostatic control of the thyroid-pituitary axis: Perspectives for diagnosis and treatment. Front. Endocrinol. 6, 177 (2015). doi:10.3389/fendo.2015.00177
R. Larisch, A. Giacobino, W. Eckl, H.G. Wahl, J.E. Midgley, R. Hoermann, Reference range for thyrotropin. Post hoc assessment. Nuklearmedizin. 54(3), 112–117 (2015). doi:10.3413/Nukmed-0671-14-06
M.I. Surks, G. Goswami, G.H. Daniels, The thyrotropin reference range should remain unchanged. J. Clin. Endocrinol. Metab. 90(9), 5489–5496 (2005). doi:10.1210/jc.2005-0170
A.S. Levey, L.A. Stevens, C.H. Schmid, Y.L. Zhang, A.F. Castro 3rd, H.I. Feldman, J.W. Kusek, P. Eggers, F. Van Lente, T. Greene, J. Coresh, E.P.I. Ckd, A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150(9), 604–612 (2009)
E.T. de los Santos, G.H. Starich, E.L. Mazzaferri, Sensitivity, specificity, and cost-effectiveness of the sensitive thyrotropin assay in the diagnosis of thyroid disease in ambulatory patients. Arch. Intern. Med. 149(3), 526–532 (1989)
D.S. Ross, H.B. Burch, D.S. Cooper, M.C. Greenlee, P. Laurberg, A.L. Maia, S. Rivkees, M. Samuels, J.A. Sosa, M.N. Stan, M. Walter, 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. (2016). doi:10.1089/thy.2016.0229
M.I. Surks, I.J. Chopra, C.N. Mariash, J.T. Nicoloff, D.H. Solomon, American thyroid association guidelines for use of laboratory tests in thyroid disorders. JAMA. 263(11), 1529–1532 (1990)
P.N. Taylor, S. Razvi, S.H. Pearce, C.M. Dayan, Clinical review: A review of the clinical consequences of variation in thyroid function within the reference range. J. Clin. Endocrinol. Metab. 98(9), 3562–3571 (2013). doi:10.1210/jc.2013-1315
C.H. Jung, M.J. Lee, Y.M. Kang, J.Y. Hwang, E.H. Kim, J.Y. Park, H.K. Kim, W.J. Lee, The risk of chronic kidney disease in a metabolically healthy obese population. Kidney. Int. 88(4), 843–850 (2015). doi:10.1038/ki.2015.183
T.D. Jeong, W. Lee, S. Chun, S.K. Lee, J.S. Ryu, W.K. Min, J.S. Park, Comparison of the MDRD study and CKD-EPI equations for the estimation of the glomerular filtration rate in the Korean general population: The fifth Korea national health and nutrition examination survey (KNHANES V-1), 2010. Kidney. Blood. Press. Res. 37(4-5), 443–450 (2013). doi:10.1159/000355724
E.Y. Lee, Y.M. Lee, K.H. Choi, H.C. Lee, B.W. Lee, B.S. Kim, Comparison of two creatinine-based equations for predicting decline in renal function in type 2 diabetic patients with nephropathy in a korean population. Int. J. Endocrinol. 2013, 848963 (2013). doi:10.1155/2013/848963
Acknowledgments
The authors are very grateful to Sin-Ho Jung and Kiyoun Kim of the Biostatistics and Clinical Epidemiology Center of Samsung Medical Center for statistical assistance in the analysis of the data for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Lee, D.Y., Jee, J.H., Jun, J.E. et al. The effect of TSH change per year on the risk of incident chronic kidney disease in euthyroid subjects. Endocrine 55, 503–512 (2017). https://doi.org/10.1007/s12020-016-1138-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-016-1138-8